| 6.0 |
18.0 |
GO:0048627 |
myoblast development(GO:0048627) |
| 5.3 |
16.0 |
GO:0019859 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 3.8 |
22.7 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 3.3 |
9.9 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 3.3 |
9.9 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 3.1 |
9.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 2.9 |
8.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.7 |
8.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 2.7 |
8.1 |
GO:1903002 |
regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 2.7 |
10.7 |
GO:0010901 |
regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 2.7 |
10.6 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 2.5 |
10.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.5 |
9.9 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 2.4 |
2.4 |
GO:1900150 |
regulation of defense response to fungus(GO:1900150) |
| 2.3 |
7.0 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 2.3 |
9.2 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 2.3 |
6.8 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 2.2 |
12.9 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 2.1 |
6.3 |
GO:0070602 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 2.1 |
6.2 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 2.0 |
6.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 2.0 |
6.0 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 2.0 |
7.9 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 2.0 |
11.7 |
GO:1902847 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 1.9 |
7.8 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.9 |
5.8 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.9 |
17.4 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) |
| 1.9 |
5.8 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.9 |
5.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.8 |
5.5 |
GO:0015755 |
fructose transport(GO:0015755) |
| 1.8 |
5.5 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 1.8 |
1.8 |
GO:0098969 |
neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 1.8 |
1.8 |
GO:0015744 |
succinate transport(GO:0015744) |
| 1.8 |
10.5 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 1.8 |
5.3 |
GO:0046146 |
tetrahydrobiopterin metabolic process(GO:0046146) |
| 1.8 |
5.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.7 |
8.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 1.7 |
8.6 |
GO:0006559 |
L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 1.7 |
6.6 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) |
| 1.6 |
11.3 |
GO:0052805 |
imidazole-containing compound catabolic process(GO:0052805) |
| 1.6 |
6.5 |
GO:0032385 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
| 1.6 |
3.2 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 1.6 |
4.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.6 |
4.7 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.6 |
6.3 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.6 |
7.8 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 1.5 |
6.2 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.5 |
4.6 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.5 |
1.5 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 1.5 |
4.5 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 1.5 |
4.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.5 |
5.9 |
GO:0043091 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 1.5 |
4.4 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 1.5 |
17.5 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.5 |
4.4 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.5 |
1.5 |
GO:0032470 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
| 1.5 |
7.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.4 |
1.4 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 1.4 |
11.5 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 1.4 |
4.3 |
GO:0001192 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.4 |
14.3 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.4 |
5.7 |
GO:1990401 |
embryonic lung development(GO:1990401) |
| 1.4 |
26.5 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 1.4 |
1.4 |
GO:1905072 |
cardiac jelly development(GO:1905072) |
| 1.4 |
4.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 1.4 |
4.1 |
GO:0061402 |
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
| 1.4 |
2.7 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 1.3 |
5.3 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.3 |
4.0 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.3 |
1.3 |
GO:0051659 |
maintenance of mitochondrion location(GO:0051659) |
| 1.3 |
10.5 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.3 |
11.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.3 |
3.9 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 1.3 |
3.9 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 1.3 |
3.9 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
| 1.3 |
6.4 |
GO:1901026 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.3 |
7.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 1.3 |
3.8 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.3 |
5.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.3 |
2.5 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 1.3 |
11.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.3 |
5.0 |
GO:0006001 |
fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 1.3 |
10.0 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 1.3 |
10.0 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 1.2 |
11.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 1.2 |
3.7 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.2 |
3.7 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 1.2 |
2.4 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 1.2 |
3.6 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 1.2 |
3.6 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 1.2 |
3.6 |
GO:1903919 |
regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
| 1.2 |
7.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 1.2 |
7.1 |
GO:0018992 |
germ-line sex determination(GO:0018992) |
| 1.2 |
3.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 1.2 |
5.9 |
GO:0031437 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 1.2 |
10.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.1 |
1.1 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 1.1 |
1.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.1 |
9.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.1 |
4.6 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 1.1 |
3.4 |
GO:0060365 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
| 1.1 |
7.8 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.1 |
3.4 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.1 |
4.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.1 |
3.3 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 1.1 |
25.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 1.1 |
1.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 1.1 |
6.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 1.1 |
4.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.0 |
1.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 1.0 |
3.1 |
GO:0015866 |
ADP transport(GO:0015866) |
| 1.0 |
3.1 |
GO:0060128 |
corticotropin hormone secreting cell differentiation(GO:0060128) |
| 1.0 |
1.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 |
3.1 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.0 |
3.0 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 1.0 |
3.0 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.0 |
11.0 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 1.0 |
8.0 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 1.0 |
1.0 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.0 |
5.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.0 |
6.0 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.0 |
6.9 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 1.0 |
6.9 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 1.0 |
5.9 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.0 |
12.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.0 |
5.9 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 1.0 |
1.0 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.0 |
2.9 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.0 |
3.9 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 1.0 |
2.9 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.0 |
5.8 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.9 |
2.8 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.9 |
3.8 |
GO:0034756 |
regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.9 |
8.4 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.9 |
5.6 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.9 |
3.7 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.9 |
0.9 |
GO:0034443 |
negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.9 |
2.8 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.9 |
0.9 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.9 |
2.8 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 0.9 |
3.6 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.9 |
1.8 |
GO:0070055 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.9 |
11.8 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.9 |
5.4 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.9 |
3.6 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.9 |
6.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.9 |
3.6 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.9 |
2.7 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.9 |
3.5 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.9 |
7.1 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.9 |
1.8 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.9 |
5.3 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.9 |
3.5 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.9 |
2.6 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.9 |
6.1 |
GO:0070777 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.9 |
3.5 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.9 |
13.8 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.9 |
2.6 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.9 |
4.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.9 |
2.6 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.9 |
3.4 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.9 |
2.6 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.9 |
2.6 |
GO:1903537 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.9 |
2.6 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 0.9 |
0.9 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.9 |
1.7 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.8 |
7.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.8 |
3.4 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.8 |
3.4 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.8 |
5.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.8 |
23.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.8 |
2.5 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.8 |
3.3 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.8 |
0.8 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.8 |
4.9 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.8 |
1.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.8 |
0.8 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.8 |
4.0 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.8 |
3.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.8 |
2.4 |
GO:0070342 |
brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
| 0.8 |
3.9 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.8 |
3.1 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.8 |
6.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.8 |
2.3 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.8 |
5.4 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.8 |
2.3 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.8 |
4.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.8 |
3.1 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.8 |
2.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.8 |
4.5 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.8 |
3.8 |
GO:0072363 |
regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
| 0.8 |
6.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.7 |
3.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.7 |
3.0 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 |
0.7 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.7 |
7.5 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.7 |
1.5 |
GO:0002485 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.7 |
2.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.7 |
3.0 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.7 |
4.4 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.7 |
12.5 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.7 |
3.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.7 |
2.2 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 |
6.6 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.7 |
8.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.7 |
1.5 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.7 |
7.3 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.7 |
3.6 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.7 |
2.9 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.7 |
10.1 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.7 |
15.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.7 |
2.9 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.7 |
0.7 |
GO:0015827 |
aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
| 0.7 |
1.4 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) regulation of establishment of T cell polarity(GO:1903903) |
| 0.7 |
0.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.7 |
3.6 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.7 |
2.8 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.7 |
2.8 |
GO:2001055 |
positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
| 0.7 |
2.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.7 |
1.4 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.7 |
2.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.7 |
3.5 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.7 |
4.8 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.7 |
8.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.7 |
2.8 |
GO:0003343 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.7 |
2.1 |
GO:0018900 |
dichloromethane metabolic process(GO:0018900) |
| 0.7 |
1.4 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.7 |
2.7 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.7 |
2.7 |
GO:0014732 |
skeletal muscle atrophy(GO:0014732) negative regulation of myoblast fusion(GO:1901740) |
| 0.7 |
2.7 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.7 |
2.7 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.7 |
8.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.7 |
1.4 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.7 |
8.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.7 |
12.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.7 |
3.4 |
GO:1903179 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.7 |
2.0 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.7 |
6.0 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.7 |
2.0 |
GO:0061193 |
taste bud development(GO:0061193) |
| 0.7 |
4.6 |
GO:0072047 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.7 |
2.0 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.7 |
1.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.6 |
1.3 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.6 |
0.6 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.6 |
6.4 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 0.6 |
1.9 |
GO:0006499 |
N-terminal protein myristoylation(GO:0006499) |
| 0.6 |
0.6 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.6 |
1.9 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.6 |
4.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 |
5.7 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.6 |
6.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 |
3.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.6 |
4.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 |
0.6 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.6 |
2.5 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.6 |
2.5 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 |
3.1 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.6 |
1.2 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.6 |
4.9 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.6 |
4.3 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.6 |
3.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.6 |
2.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.6 |
3.1 |
GO:0070444 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.6 |
1.8 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.6 |
10.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.6 |
4.2 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.6 |
5.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.6 |
2.4 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.6 |
3.5 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.6 |
1.8 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 |
1.2 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.6 |
2.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.6 |
5.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.6 |
1.8 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.6 |
2.9 |
GO:0060573 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.6 |
2.3 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.6 |
2.9 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.6 |
6.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.6 |
5.1 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.6 |
1.7 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.6 |
1.7 |
GO:1904057 |
negative regulation of sensory perception of pain(GO:1904057) |
| 0.6 |
8.0 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.6 |
4.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.6 |
0.6 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.6 |
4.0 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.6 |
3.4 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.6 |
1.7 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.6 |
2.8 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.6 |
26.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.6 |
7.9 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.6 |
3.9 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.6 |
2.3 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.6 |
2.8 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.6 |
1.7 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.6 |
1.7 |
GO:0048104 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.6 |
3.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.6 |
0.6 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.6 |
1.1 |
GO:2000439 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 0.6 |
0.6 |
GO:0021502 |
neural fold elevation formation(GO:0021502) |
| 0.5 |
1.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 |
1.6 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.5 |
2.2 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.5 |
1.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.5 |
12.4 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.5 |
2.1 |
GO:0002489 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.5 |
0.5 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.5 |
1.6 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.5 |
0.5 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.5 |
2.1 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.5 |
4.2 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.5 |
1.1 |
GO:0097033 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.5 |
1.6 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.5 |
1.6 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.5 |
1.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.5 |
2.6 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
0.5 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.5 |
3.7 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.5 |
1.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.5 |
1.6 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.5 |
3.6 |
GO:0009188 |
ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.5 |
9.3 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.5 |
1.5 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.5 |
1.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.5 |
3.6 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.5 |
1.0 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.5 |
1.5 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.5 |
2.6 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.5 |
4.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.5 |
2.0 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.5 |
2.5 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.5 |
2.0 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 |
3.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
1.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.5 |
0.5 |
GO:0010845 |
regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.5 |
1.5 |
GO:0007529 |
establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
| 0.5 |
2.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 |
3.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.5 |
7.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.5 |
8.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.5 |
2.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 |
8.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.5 |
1.5 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.5 |
2.0 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.5 |
1.5 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.5 |
1.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 |
0.5 |
GO:0060336 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.5 |
5.9 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
1.0 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.5 |
1.9 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.5 |
3.4 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.5 |
1.4 |
GO:0009397 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.5 |
1.4 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.5 |
8.6 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.5 |
20.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.5 |
2.4 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.5 |
6.7 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.5 |
1.4 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.5 |
8.0 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.5 |
2.4 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.5 |
1.9 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.5 |
1.4 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.5 |
1.4 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.5 |
1.4 |
GO:0060978 |
angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.5 |
2.8 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.5 |
1.9 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.5 |
1.9 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.5 |
0.9 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.5 |
0.5 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.5 |
1.4 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.5 |
6.4 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.5 |
0.9 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.5 |
6.9 |
GO:0046461 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.5 |
0.9 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.5 |
2.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
2.3 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.5 |
6.0 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.5 |
2.3 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.5 |
1.8 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.5 |
4.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.5 |
11.4 |
GO:0080184 |
response to phenylpropanoid(GO:0080184) |
| 0.5 |
0.9 |
GO:0010887 |
negative regulation of cholesterol storage(GO:0010887) |
| 0.5 |
1.4 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.5 |
2.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.4 |
2.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.4 |
2.7 |
GO:0098963 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.4 |
3.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.4 |
3.6 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.4 |
5.4 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 |
6.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
2.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.4 |
1.8 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 0.4 |
0.4 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.4 |
1.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.4 |
7.0 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.4 |
2.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 |
1.8 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
2.6 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.4 |
0.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
1.3 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.4 |
2.2 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.4 |
0.9 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.4 |
1.3 |
GO:0021843 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.4 |
1.3 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.4 |
0.9 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.4 |
0.4 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.4 |
1.7 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 |
2.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 |
3.4 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.4 |
13.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.4 |
1.3 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.4 |
1.7 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.4 |
0.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.4 |
1.7 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.4 |
1.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
1.2 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.4 |
1.2 |
GO:0090382 |
phagosome maturation(GO:0090382) |
| 0.4 |
1.2 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) |
| 0.4 |
1.7 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.4 |
2.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
1.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.4 |
3.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.4 |
2.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.4 |
3.3 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.4 |
2.0 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 |
2.5 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.4 |
1.2 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.4 |
1.6 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.4 |
1.2 |
GO:0033577 |
protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.4 |
0.8 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.4 |
6.0 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.4 |
2.4 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 |
2.4 |
GO:0075071 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.4 |
1.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.4 |
1.6 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 |
2.4 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
1.6 |
GO:0090282 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
| 0.4 |
1.6 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.4 |
4.7 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 |
0.8 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.4 |
1.2 |
GO:0042851 |
L-alanine metabolic process(GO:0042851) |
| 0.4 |
5.0 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.4 |
3.5 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.4 |
2.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
5.0 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.4 |
1.1 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.4 |
2.7 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.4 |
1.1 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.4 |
1.1 |
GO:0051594 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 |
1.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 |
1.1 |
GO:1903679 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
4.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 |
1.9 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.4 |
1.5 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 |
1.5 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.4 |
3.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 |
1.9 |
GO:0021637 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.4 |
0.8 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
0.8 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.4 |
1.5 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
0.7 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
| 0.4 |
0.7 |
GO:0045818 |
negative regulation of glycogen catabolic process(GO:0045818) |
| 0.4 |
1.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 |
5.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 |
1.1 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.4 |
2.2 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.4 |
1.1 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.4 |
0.7 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.4 |
0.4 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.4 |
1.5 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.4 |
4.4 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 |
1.1 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.4 |
2.5 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.4 |
1.4 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.4 |
1.1 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.4 |
1.4 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.4 |
0.7 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.4 |
1.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.4 |
2.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.4 |
0.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
| 0.4 |
1.1 |
GO:0045643 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.4 |
1.4 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.3 |
2.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 |
0.7 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 |
0.3 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.3 |
0.7 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 |
1.0 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.3 |
4.5 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 |
3.8 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.3 |
1.0 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.3 |
1.0 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.3 |
1.4 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.3 |
0.7 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.3 |
0.7 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.3 |
1.0 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 |
0.7 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.3 |
2.0 |
GO:0072307 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.3 |
1.0 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.3 |
1.3 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
1.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 |
1.0 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.3 |
2.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
1.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
0.7 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.3 |
1.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.3 |
5.6 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.3 |
0.7 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.3 |
1.0 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.3 |
2.0 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.3 |
0.7 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.3 |
1.0 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.3 |
0.7 |
GO:1903797 |
positive regulation of inorganic anion transmembrane transport(GO:1903797) |
| 0.3 |
1.9 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.3 |
9.1 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.3 |
1.0 |
GO:0071455 |
cellular response to hyperoxia(GO:0071455) |
| 0.3 |
1.6 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.3 |
0.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 |
1.9 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.3 |
0.6 |
GO:0009169 |
ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.3 |
0.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
8.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
1.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
1.0 |
GO:1902220 |
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
| 0.3 |
1.9 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.3 |
1.0 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) |
| 0.3 |
2.2 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.3 |
0.3 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.3 |
2.5 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.3 |
1.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
1.3 |
GO:0018317 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 |
0.6 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 |
0.3 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.3 |
1.6 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 |
0.6 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.3 |
0.9 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 |
6.1 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.3 |
0.9 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 |
0.9 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.3 |
0.6 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.3 |
2.1 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.3 |
5.8 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.3 |
1.5 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.3 |
0.9 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.6 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 |
1.5 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.3 |
0.9 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
1.5 |
GO:1904628 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.3 |
0.9 |
GO:0048840 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.3 |
1.8 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.3 |
0.9 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.3 |
4.7 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.3 |
0.9 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.3 |
2.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
4.7 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.3 |
1.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
2.9 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.3 |
0.9 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.3 |
0.9 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
1.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 |
12.0 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
1.1 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.3 |
0.6 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
1.1 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.3 |
2.6 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
3.7 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
2.8 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.3 |
1.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
3.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.3 |
0.6 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
0.6 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.3 |
2.8 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 |
2.2 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.3 |
0.3 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.3 |
1.9 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
0.3 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.3 |
1.1 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.3 |
2.5 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.3 |
1.1 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.3 |
0.3 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.3 |
2.7 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.3 |
0.3 |
GO:1904444 |
regulation of establishment of Sertoli cell barrier(GO:1904444) |
| 0.3 |
0.8 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.3 |
6.8 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 |
1.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.3 |
0.5 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.3 |
0.3 |
GO:0060702 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.3 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.3 |
0.3 |
GO:0021530 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 |
1.1 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
3.0 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
1.6 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 |
1.3 |
GO:0052204 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
1.6 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.3 |
1.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
0.8 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
11.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
0.8 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.3 |
1.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 |
2.9 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 |
3.9 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
1.6 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.3 |
0.3 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
1.3 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 |
1.6 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
2.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.3 |
1.0 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.3 |
1.3 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.3 |
0.3 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
0.3 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.3 |
0.8 |
GO:0050973 |
detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
| 0.3 |
1.3 |
GO:0030638 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 |
3.1 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.3 |
0.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
0.8 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.3 |
2.0 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.3 |
1.0 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.3 |
1.3 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.3 |
0.3 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.3 |
1.0 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 |
1.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
2.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
1.3 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.3 |
1.8 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.3 |
0.5 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.2 |
1.7 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
0.5 |
GO:0002461 |
tolerance induction dependent upon immune response(GO:0002461) |
| 0.2 |
6.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
1.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
1.7 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.2 |
1.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
1.9 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
3.9 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 |
0.5 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
2.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
2.7 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.2 |
1.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
1.0 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
0.5 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
0.5 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.2 |
1.0 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 |
1.4 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.7 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 |
1.2 |
GO:0021513 |
spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.2 |
3.8 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
5.4 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.2 |
0.9 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 |
0.7 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.2 |
0.5 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.2 |
2.8 |
GO:2001273 |
regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 |
1.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.2 |
0.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
0.2 |
GO:0032826 |
natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.2 |
0.7 |
GO:0048209 |
regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.2 |
4.0 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.2 |
2.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
4.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
1.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
0.7 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.2 |
1.4 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 |
2.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
1.6 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.2 |
0.2 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.2 |
5.8 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 |
0.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.2 |
1.6 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 |
3.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.2 |
0.7 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 |
10.0 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.2 |
2.9 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.2 |
0.7 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
1.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
2.6 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.2 |
0.2 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) |
| 0.2 |
0.2 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 |
3.1 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.2 |
0.7 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.2 |
1.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
1.1 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 |
1.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.2 |
1.3 |
GO:0098597 |
observational learning(GO:0098597) |
| 0.2 |
0.2 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.2 |
1.3 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 |
1.7 |
GO:0060452 |
positive regulation of cardiac muscle contraction(GO:0060452) |
| 0.2 |
3.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
1.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.2 |
0.2 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.2 |
0.8 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
1.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
0.8 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.2 |
1.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
1.7 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
1.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
0.2 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.2 |
1.9 |
GO:0035268 |
protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
| 0.2 |
1.7 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
1.7 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.2 |
1.4 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.2 |
1.0 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.2 |
0.2 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
8.2 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.2 |
0.6 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 |
0.6 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.2 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
1.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
0.2 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.2 |
0.6 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
1.8 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
0.4 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 |
0.4 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.2 |
0.4 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.2 |
1.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
4.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
2.4 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 |
2.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.2 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.2 |
0.4 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.2 |
3.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
0.6 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 |
0.2 |
GO:0002477 |
antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.2 |
0.8 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
1.9 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.2 |
3.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.2 |
1.2 |
GO:0019217 |
regulation of fatty acid metabolic process(GO:0019217) |
| 0.2 |
0.8 |
GO:0009449 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
1.0 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 |
1.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
0.8 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
1.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.8 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.6 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.2 |
1.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.2 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
1.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.2 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 |
1.3 |
GO:0097647 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 |
0.6 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) regulation of collagen catabolic process(GO:0010710) |
| 0.2 |
1.1 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.2 |
0.7 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.2 |
0.7 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 |
0.6 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.2 |
0.7 |
GO:0061744 |
motor behavior(GO:0061744) |
| 0.2 |
0.4 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.2 |
0.6 |
GO:0090155 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
0.4 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
5.5 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.2 |
0.6 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
1.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.2 |
GO:0009838 |
abscission(GO:0009838) |
| 0.2 |
0.5 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
1.6 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.2 |
1.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
0.9 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
4.2 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.2 |
0.9 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 |
1.1 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.7 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
1.5 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.2 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
0.9 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
1.8 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.2 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.2 |
0.7 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
1.2 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.2 |
1.1 |
GO:1903543 |
positive regulation of exosomal secretion(GO:1903543) |
| 0.2 |
1.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
0.5 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.2 |
0.3 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.2 |
0.2 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.2 |
0.3 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.2 |
1.7 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
0.2 |
GO:0010885 |
regulation of cholesterol storage(GO:0010885) |
| 0.2 |
1.7 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
0.5 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.2 |
1.7 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.2 |
1.2 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
1.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
0.7 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.3 |
GO:0033483 |
gas homeostasis(GO:0033483) nitric oxide homeostasis(GO:0033484) |
| 0.2 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
0.7 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.2 |
0.3 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 |
1.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.2 |
0.2 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
4.7 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
7.0 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.2 |
0.2 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.2 |
0.8 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.7 |
GO:0002828 |
regulation of type 2 immune response(GO:0002828) |
| 0.2 |
0.7 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.2 |
0.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.5 |
GO:1902961 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 |
1.1 |
GO:0045060 |
negative thymic T cell selection(GO:0045060) |
| 0.2 |
0.5 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.2 |
5.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
0.3 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.2 |
0.9 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.2 |
0.3 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.2 |
0.9 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
2.0 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.2 |
0.8 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
0.9 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.2 |
0.3 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.2 |
0.6 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
0.5 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
0.3 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.2 |
0.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
1.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
0.3 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
6.3 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.2 |
0.2 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.2 |
0.5 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.2 |
1.5 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.2 |
1.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
1.2 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
2.2 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 |
0.6 |
GO:0002583 |
regulation of antigen processing and presentation of peptide antigen(GO:0002583) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 0.1 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
0.1 |
GO:0043545 |
molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.7 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
0.1 |
GO:0042374 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 |
0.6 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
2.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
1.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
6.0 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
1.3 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.6 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
1.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.4 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.1 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
3.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
2.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
1.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.6 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
0.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.6 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
1.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
3.9 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.1 |
0.3 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.1 |
4.4 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
2.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.3 |
GO:2000384 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 |
2.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
1.9 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 |
0.4 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.1 |
1.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
3.2 |
GO:1902652 |
secondary alcohol metabolic process(GO:1902652) |
| 0.1 |
1.5 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
1.6 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.1 |
0.7 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
2.6 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
4.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.6 |
GO:0035549 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 |
3.3 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.1 |
0.6 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.3 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 |
2.4 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.1 |
0.4 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 |
0.5 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.1 |
0.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.1 |
GO:0048165 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.4 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.6 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
5.4 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.2 |
GO:0003272 |
endocardial cushion formation(GO:0003272) |
| 0.1 |
2.2 |
GO:0060384 |
innervation(GO:0060384) |
| 0.1 |
0.7 |
GO:0010575 |
positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.2 |
GO:0034033 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 |
0.7 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
3.4 |
GO:0032012 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.9 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.2 |
GO:0010705 |
meiotic DNA double-strand break processing(GO:0000706) meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
| 0.1 |
0.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.2 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.1 |
1.2 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.1 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
0.9 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.5 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
1.3 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
2.0 |
GO:1901264 |
carbohydrate derivative transport(GO:1901264) |
| 0.1 |
0.7 |
GO:0035284 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.5 |
GO:0099404 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.1 |
0.6 |
GO:0010613 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.3 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.1 |
1.0 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.7 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
1.1 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
1.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.3 |
GO:0098728 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.8 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
2.9 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
1.0 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
1.9 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 |
0.6 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.3 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.2 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.8 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
1.6 |
GO:0099514 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.1 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
1.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.4 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
0.6 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.4 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.1 |
3.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
1.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.2 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
0.2 |
GO:0060618 |
nipple development(GO:0060618) |
| 0.1 |
1.3 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.1 |
GO:1905038 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
0.9 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
1.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.2 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.2 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.1 |
0.4 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.4 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.3 |
GO:0014048 |
regulation of glutamate secretion(GO:0014048) |
| 0.1 |
0.4 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
1.0 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.8 |
GO:0033131 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.1 |
0.8 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
1.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.6 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.3 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.4 |
GO:0010286 |
heat acclimation(GO:0010286) |
| 0.1 |
0.7 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
1.1 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 |
0.3 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.5 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.5 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
0.5 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
0.4 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.4 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.4 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.4 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.1 |
0.8 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 |
0.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.3 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 |
0.2 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.1 |
1.0 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.1 |
0.9 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.3 |
GO:0042640 |
anagen(GO:0042640) |
| 0.1 |
0.3 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.1 |
4.2 |
GO:0046426 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.5 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.6 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.2 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.1 |
0.8 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.3 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.1 |
0.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
1.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.9 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
2.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.6 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
1.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.3 |
GO:0001905 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
| 0.1 |
0.1 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.1 |
0.2 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
0.7 |
GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
| 0.1 |
0.4 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.1 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 |
0.1 |
GO:0060525 |
prostate glandular acinus development(GO:0060525) |
| 0.1 |
0.8 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.3 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
0.3 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.1 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.1 |
0.2 |
GO:0021934 |
hindbrain tangential cell migration(GO:0021934) |
| 0.1 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.7 |
GO:0072329 |
monocarboxylic acid catabolic process(GO:0072329) |
| 0.1 |
0.3 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
1.6 |
GO:0061049 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.7 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.1 |
0.8 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.1 |
GO:2000229 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.7 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.4 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
2.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.5 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.4 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
0.3 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
1.1 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.1 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.4 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
1.7 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.1 |
0.2 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 |
0.1 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
0.2 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
1.0 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
1.0 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.3 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
0.2 |
GO:0003266 |
regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.1 |
0.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
2.4 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
0.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.3 |
GO:0048313 |
organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.7 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.6 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.1 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
0.1 |
GO:0060220 |
camera-type eye photoreceptor cell fate commitment(GO:0060220) |
| 0.1 |
0.3 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.3 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.1 |
0.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.2 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.1 |
0.2 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:0043634 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.2 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
0.2 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.4 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.1 |
0.3 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
2.0 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
1.7 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0042069 |
regulation of catecholamine metabolic process(GO:0042069) |
| 0.0 |
0.1 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.0 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.0 |
0.1 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.0 |
0.2 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.2 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.0 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.3 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 |
0.5 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 |
0.3 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.3 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.0 |
0.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.3 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.4 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.2 |
GO:0050706 |
regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 |
0.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 |
0.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.0 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
3.0 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.1 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.0 |
0.5 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.0 |
0.2 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.0 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.0 |
0.8 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 |
0.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.3 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 |
0.1 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.2 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0008595 |
blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.0 |
0.1 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.0 |
0.5 |
GO:0018904 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.1 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.3 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.2 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.0 |
0.0 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.0 |
0.5 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.6 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.0 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.5 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.2 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.1 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 |
0.5 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.6 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.2 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.3 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.0 |
0.1 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.0 |
0.1 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.0 |
GO:0060713 |
labyrinthine layer morphogenesis(GO:0060713) |
| 0.0 |
0.0 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.0 |
0.3 |
GO:0001958 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.1 |
GO:0061436 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 |
0.0 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
1.1 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
